Melanocortin 4 receptor mutations in a large cohort of severely obese adults: Prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating

被引:174
作者
Lubrano-Berthelier, C
Dubern, B
Lacorte, JM
Picard, F
Shapiro, A
Zhang, SM
Bertrais, S
Hercberg, S
Basdevant, A
Clement, K
Vaisse, C
机构
[1] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Paris 06, INSERM Avenir, F-75004 Paris, France
[4] Univ Paris 06, Equipe Accueil 3502, F-75004 Paris, France
[5] Univ Paris 06, Inst Federat Rech 58, F-75004 Paris, France
[6] Ctr Hosp Reg Univ Pitie Salpetriere, Ctr Rech Nutr Humaine ILe France, Hotel Dieu, F-75004 Paris, France
[7] Armand Trousseau Teaching Hosp, Dept Pediat Gastroenterol & Nutr, Paris, France
[8] Hop Hotel Dieu, Dept Biochem, F-75181 Paris, France
[9] Inst Sci & Tech Nutr & Alimentat Conservatoire Na, UMR INSERM Unit 557, Inst Natl Rech Agron Unit 1125, F-75003 Paris, France
关键词
D O I
10.1210/jc.2005-1411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Heterozygous mutations in the melanocortin-4 receptor (MC4R) gene are the most common monogenic form of severe obesity in children. There are conflicting reports regarding the prevalence, nature, and pathogenic effects of MC4R mutations in adults with severe late-onset obesity. Objective: Our objective was to determine the prevalence of MC4R mutations in a cohort of severely obese adults and to determine the clinical phenotype and the phenotype-genotype relationship within adult MC4R mutation carriers. Design and Setting: We conducted an observational study at a referral center. Patients or Other Participants: Participants included 769 adult patients with body mass index of at least 35 kg/m(2) and 444 nonobese control individuals. Interventions: There were no interventions. Main Outcome Measures: We assessed the prevalence of pathogenic MC4R mutations, functional characteristics of the detected mutations, phenotype, and phenotype- genotype relationship within mutation carriers. Results: The global prevalence of obesity-specific MC4R mutations was 2.6%, and the 95% confidence interval (CI95) was 1.5 - 3.7. The prevalence of MC4R mutations was similar in patients developing obesity in childhood (2.83%; CI95, 0.9 - 4.8) and in patients with a later onset of the disease (2.35%; CI95, 0.9 - 3.8). Adult obese MC4R mutation carriers did not present with binge eating or with any specific clinical phenotype. The severity of the functional alterations of the mutated MC4Rs and in particular the intracellular retention of the receptor correlates both with the severity and the onset of the obesity in the mutation carriers. Conclusions: Obese adult carriers of functionally relevant MC4R mutations do not specifically present with binge-eating disorder or a history of early- onset obesity. The onset and severity of the obesity in the carriers is related to the functional severity of the MC4R mutations.
引用
收藏
页码:1811 / 1818
页数:8
相关论文
共 45 条
[31]  
ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13
[32]   Genetic screening for melanocortin-4 receptor mutations in a cohort of Italian obese patients: Description and functional characterization of a novel mutation [J].
Santini, F ;
Maffei, M ;
Ceccarini, G ;
Pelosini, C ;
Scartabelli, G ;
Rosellini, V ;
Chiellini, C ;
Marsili, A ;
Lisi, S ;
Tonacchera, M ;
Agretti, P ;
Chiovato, L ;
Mammoli, C ;
Vitti, P ;
Pinchera, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :904-908
[33]   Central nervous system control of food intake [J].
Schwartz, MW ;
Woods, SC ;
Porte, D ;
Seeley, RJ ;
Baskin, DG .
NATURE, 2000, 404 (6778) :661-671
[34]   Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene [J].
Sina, M ;
Hinney, A ;
Ziegler, A ;
Neupert, T ;
Mayer, H ;
Siegfried, W ;
Blum, WF ;
Remschmidt, H ;
Hebebrand, J .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (06) :1501-1507
[35]  
SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0
[36]  
SPITZER RL, 1993, INT J EAT DISORDER, V13, P161, DOI 10.1002/1098-108X(199303)13:2&lt
[37]  
161::AID-EAT2260130204&gt
[38]  
3.0.CO
[39]  
2-R
[40]  
SPITZER RL, 1993, INT J EAT DISORDER, V13, P137, DOI 10.1002/1098-108X(199303)13:2&lt